More than a decade after sustaining an injury in Afghanistan, Matt Dumper lost his leg. The Army Benevolent Fund was still ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

The 6-foot-6, 250-pound tight end who this past week announced his transfer to Purdue amid coaching turnover in Winston-Salem ...

Nauwkeurige geolocatiegegevens gebruiken en actief apparaatkenmerken scannen voor identificatie. Dit doen wij om informatie ...

Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Eli Lilly (LLY) is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks ...

Juan M. Morales Juan M. Morales, a devoted husband, father, grandfather, and friend, peacefully passed away at home on Dec. 31, 2024, at the age of 87, ...

Eli Lilly in talks to acquire cancer biotech Scorpion Therapeutics for $2.5 billion, with potential milestone payments.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...